Platinum Resistant | List of Frontiers open access articles

Original Research

Published on 03 May 2022

MiR-320b and miR-320d as Biomarkers to Predict and Participate in the Formation of Platinum Resistance in Ovarian Cancer Patients

in Gynecological Oncology

Yuan-Yuan Liu
Ren-Feng Zhao
Chao Liu
Jie Zhou
Liu Yang
Li Li

Frontiers in Oncology

doi 10.3389/fonc.2022.881496

3,063 views
12 citations

Review

Published on 17 Oct 2023

Overcoming the challenges of drug development in platinum-resistant ovarian cancer

in Gynecological Oncology

Ramez N. Eskander
Kathleen N. Moore
Bradley J. Monk
Thomas J. Herzog
Christina M. Annunziata
David M. O’Malley
Robert L. Coleman

Frontiers in Oncology

doi 10.3389/fonc.2023.1258228

15,728 views
31 citations

Original Research

Published on 02 Dec 2022

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy

in Cancer Genetics

Karolina Seborova
Viktor Hlavac
Petr Holy
Sunniva S. Bjørklund
Thomas Fleischer
Lukas Rob
Martin Hruda
Jiri Bouda
Marcela Mrhalova
Mohammad Moufaq Khatar Al Obeed Allah

Frontiers in Oncology

doi 10.3389/fonc.2022.1016958

3,937 views
6 citations

Review

Published on 22 Aug 2023

Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer

in Gynecological Oncology

Jinbowen Yan
Fangzhi Xu
Dan Zhou
Shuo Zhang
Bo Zhang
Qingwei Meng
Qiubo Lv

Frontiers in Oncology

doi 10.3389/fonc.2023.1231460

5,238 views
6 citations

Original Research

Published on 25 Nov 2022

Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer

in Gynecological Oncology

David Howard
David James
Jezabel Garcia-Parra
Belen Pan-Castillo
Jenny Worthington
Nicole Williams
Zoe Coombes
Sophie Colleen Rees
Kerryn Lutchman-Singh
Lewis W. Francis

Frontiers in Oncology

doi 10.3389/fonc.2022.1014280

5,687 views
13 citations

Case Report

Published on 27 Mar 2024

Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation

in Gynecological Oncology

Mariko Peterson
David L. Kolin
Panagiotis A. Konstantinopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1357980

2,743 views

Case Report

Published on 03 Jan 2024

Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer

in Cancer Immunity and Immunotherapy

Yi Qin
Shangke Huang
Junli Tang
Yu Fan
Xiangyu Deng
Ping Guan
Zhenhua Zhang
Qinglian Wen
Dan Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1329951

2,895 views
5 citations

Original Research

Published on 07 Jul 2014

Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth

in Cancer Molecular Targets and Therapeutics

Jolijn W. Groeneweg
Celeste M. DiGloria
Jing Yuan
William S. Richardson
Whitfield B. Growdon
Sriram Sathyanarayanan
Rosemary Foster
Bo R. Rueda

Frontiers in Oncology

doi 10.3389/fonc.2014.00171

8,693 views
43 citations

Systematic Review

Published on 11 Apr 2023

Treatment options for recurrent platinum-resistant ovarian cancer: A systematic review and Bayesian network meta-analysis based on RCTs

in Gynecological Oncology

Juan Li
Guorong Zou
Wei Wang
Chen Yin
Haowen Yan
Shengpeng Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1114484

15,459 views
6 citations

Brief Research Report

Published on 19 Aug 2020

Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer

in Pharmacology of Anti-Cancer Drugs

Ram N. Ganapathi
Eric J. Norris
Ashley P. Sutker
Kaitlin E. Klotz
Mahrukh K. Ganapathi

Frontiers in Oncology

doi 10.3389/fonc.2020.01354

3,904 views
5 citations

Original Research

Published on 02 Aug 2021

Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer

in Cancer Immunity and Immunotherapy

Hongyan Cheng
Ruiqiong Ma
Shang Wang
Yu Wang
Yingchun Li
Zhijian Tang
Sha Dou
Yuanfen Wang
Honglan Zhu
Xue Ye

Frontiers in Immunology

doi 10.3389/fimmu.2021.707468

7,619 views
5 citations

Case Report

Published on 20 Aug 2025

Pembrolizumab combined with lenvatinib and metronomic cyclophosphamide in platinum-resistant ovarian cancer: a case report of durable clinical response

in Gynecological Oncology

Guanlin Dai
Furong Tang
Ping Wang
Danqing Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1582701

2,491 views

Review

Published on 05 Jun 2023

Characterization of global research trends and prospects on platinum-resistant ovarian cancer: a bibliometric analysis

in Gynecological Oncology

Yuanqiong Duan
Peixuan Zhang
Tianyue Zhang
Lu Zhou
Rutie Yin

Frontiers in Oncology

doi 10.3389/fonc.2023.1151871

5,326 views
17 citations

Original Research

Published on 23 Nov 2021

High Serpin Family A Member 10 Expression Confers Platinum Sensitivity and Is Associated With Survival Benefit in High-Grade Serous Ovarian Cancer: Based on Quantitative Proteomic Analysis

in Gynecological Oncology

Wenwen Guo
Xue He
Jing Ni
Liya Ma
Xianzhong Cheng
Congyang Wang
Xiaoxiang Chen
Yan Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.761960

4,273 views
15 citations

Original Research

Published on 07 Jul 2022

High Expression of PARP1 in Tumor and Stroma Cells Predicts Different Prognosis and Platinum Resistance in Patients With Advanced Epithelial Ovarian Cancer

in Cancer Molecular Targets and Therapeutics

Wei-Wei Zuo
Chun-Fang Zhao
Yan Li
Hai-Yan Sun
Guo-Ming Ma
Yue-Ping Liu
Shan Kang

Frontiers in Oncology

doi 10.3389/fonc.2022.931445

3,488 views
8 citations

Case Report

Published on 07 Feb 2025

Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report

in Head and Neck Cancer

Tomoyuki Otsuka
Yoshiki Kojitani
Fumio Imamura
Junko Fukutake
Minako Nishio
Takashi Fujii
Toshihiro Kudo

Frontiers in Oncology

doi 10.3389/fonc.2025.1508682

2,120 views
1 citation

Articles

MiR-320b and miR-320d as Biomarkers to Predict and Participate in the Formation of Platinum Resistance in Ovarian Cancer Patients

Overcoming the challenges of drug development in platinum-resistant ovarian cancer

Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy

Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer

Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer

Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation

Case report: Interstitial implantation radiotherapy combined with immunotherapy and GM-CSF in oligometastatic platinum-resistant ovarian cancer

Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth

Treatment options for recurrent platinum-resistant ovarian cancer: A systematic review and Bayesian network meta-analysis based on RCTs

Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer

Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer

Pembrolizumab combined with lenvatinib and metronomic cyclophosphamide in platinum-resistant ovarian cancer: a case report of durable clinical response

Characterization of global research trends and prospects on platinum-resistant ovarian cancer: a bibliometric analysis

High Serpin Family A Member 10 Expression Confers Platinum Sensitivity and Is Associated With Survival Benefit in High-Grade Serous Ovarian Cancer: Based on Quantitative Proteomic Analysis

High Expression of PARP1 in Tumor and Stroma Cells Predicts Different Prognosis and Platinum Resistance in Patients With Advanced Epithelial Ovarian Cancer

Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report